18585843

Source:http://linkedlifedata.com/resource/pubmed/id/18585843

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017262, umls-concept:C0030705, umls-concept:C0042071, umls-concept:C0185117, umls-concept:C0194810, umls-concept:C0443199, umls-concept:C1514307, umls-concept:C1522496, umls-concept:C1622667, umls-concept:C2911684
pubmed:issue	5
pubmed:dateCreated	2009-7-29
pubmed:abstractText	The urokinase plasminogen axis is composed of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitors (PAI-1 and PAI-2). This axis is involved in cell proliferation, angiogenesis, extracellular matrix degradation, invasion, and metastases.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18585843-18585844, http://linkedlifedata.com/resource/pubmed/commentcorrection/18585843-18585847
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7512719
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Urokinase Plasminogen..., http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1873-7560
pubmed:author	pubmed-author:AragakiCorinne CCC, pubmed-author:AshfaqRaheelaR, pubmed-author:GuptaAmitA, pubmed-author:LotanYairY, pubmed-author:MontorsiFrancescoF, pubmed-author:RajGanesh VGV, pubmed-author:RoehrbornClaus GCG, pubmed-author:ShariatShahrokh FSF
pubmed:issnType	Electronic
pubmed:volume	55
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1124-33
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:18585843-Aged, pubmed-meshheading:18585843-Aged, 80 and over, pubmed-meshheading:18585843-Analysis of Variance, pubmed-meshheading:18585843-Biopsy, Needle, pubmed-meshheading:18585843-Cohort Studies, pubmed-meshheading:18585843-Disease-Free Survival, pubmed-meshheading:18585843-Follow-Up Studies, pubmed-meshheading:18585843-Gene Expression Regulation, Neoplastic, pubmed-meshheading:18585843-Humans, pubmed-meshheading:18585843-Immunohistochemistry, pubmed-meshheading:18585843-Kaplan-Meier Estimate, pubmed-meshheading:18585843-Male, pubmed-meshheading:18585843-Middle Aged, pubmed-meshheading:18585843-Multivariate Analysis, pubmed-meshheading:18585843-Neoplasm Recurrence, Local, pubmed-meshheading:18585843-Neoplasm Staging, pubmed-meshheading:18585843-Predictive Value of Tests, pubmed-meshheading:18585843-Probability, pubmed-meshheading:18585843-Proportional Hazards Models, pubmed-meshheading:18585843-Prostatectomy, pubmed-meshheading:18585843-Prostatic Neoplasms, pubmed-meshheading:18585843-Receptors, Urokinase Plasminogen Activator, pubmed-meshheading:18585843-Retrospective Studies, pubmed-meshheading:18585843-Risk Assessment, pubmed-meshheading:18585843-Survival Analysis, pubmed-meshheading:18585843-Treatment Outcome, pubmed-meshheading:18585843-Tumor Markers, Biological
pubmed:year	2009
pubmed:articleTitle	Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
pubmed:affiliation	Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA.
pubmed:publicationType	Journal Article